Ginkgo Bioworks Holdings (DNA) Other financing activities (2021 - 2025)
Ginkgo Bioworks Holdings (DNA) reported Other financing activities of $985000.0 for Q4 2025, up 12212.5% on a YoY basis from N/an in Q4 2024, and up 12212.5% quarter-over-quarter from $8000.0 in Q4 2024.
Ginkgo Bioworks Holdings (DNA) Other financing activities (2021 - 2025) Analysis & Trends
Ginkgo Bioworks Holdings has reported Other financing activities for 5 years, with the latest figure at $985000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities rose 12212.5% year-over-year to $985000.0; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (up 162.44% YoY), and the FY2025 full-year result was $1.3 million, up 33400.0% from the prior year.
- Other financing activities for Q4 2025 stood at $985000.0, up from $8000.0 in the prior quarter.
- The five-year high for Other financing activities was $34.1 million in Q3 2021, with the low at -$88000.0 in Q3 2022.
- Historically, Other financing activities has averaged $5.7 million across 5 years, with a median of $155760.0 in 2021.
- Annual changes were most pronounced in 2024 — Other financing activities sank 300.0% — and 2025, when it jumped 12212.5%.
- Ginkgo Bioworks Holdings' Other financing activities stood at -$67000.0 in 2021, then jumped by 1582.09% to $993000.0 in 2022, then slumped by 39.17% to $604000.0 in 2023, then plunged by 98.68% to $8000.0 in 2024, then jumped by 12212.5% to $985000.0 in 2025.
- The last three Other financing activities figures came in at $985000.0 (Q4 2025), $8000.0 (Q4 2024), and -$4000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 985,000.00 |
| Dec 31, 2025 | 985,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Dec 31, 2023 | 604,000.00 |
| Dec 31, 2023 | 604,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2022 | 993,000.00 |
| Dec 31, 2022 | 993,000.00 |
| Sep 30, 2022 | -88,000.00 |
| Sep 30, 2022 | -88,000.00 |
| Dec 31, 2021 | -67,000.00 |
| Dec 31, 2021 | -67,000.00 |
| Sep 30, 2021 | 34.13 Mn |
| Sep 30, 2021 | 34.13 Mn |
| Jun 30, 2021 | 25.72 Mn |
| Jun 30, 2021 | 25.72 Mn |